Outcomes of a nine-month regimen for rifampicin-resistant tuberculosis up to 24 months after treatment completion in nine African countries

BACKGROUND: Treatment outcomes of the shorter regimen for rifampicin-resistant tuberculosis are not completely established. We report on these outcomes two years after treatment completion among patients enrolled in an observational cohort study in nine African countries. METHODS: 1,006 patients tre...

Descripción completa

Detalles Bibliográficos
Autores principales: Schwœbel, Valérie, Trébucq, Arnaud, Kashongwe, Zacharie, Bakayoko, Alimata S., Kuaban, Christopher, Noeske, Juergen, Harouna, Souleymane H., Souleymane, Mahamadou B., Piubello, Alberto, Ciza, François, Fikouma, Valentin, Gasana, Michel, Ouedraogo, Martial, Gninafon, Martin, Van Deun, Armand, Tagliani, Elisa, Cirillo, Daniela M., Koura, Kobto G., Rieder, Hans L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Research paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7152829/
https://www.ncbi.nlm.nih.gov/pubmed/32300732
http://dx.doi.org/10.1016/j.eclinm.2020.100268

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7152829/
https://www.ncbi.nlm.nih.gov/pubmed/32300732
http://dx.doi.org/10.1016/j.eclinm.2020.100268

Ejemplares similares